Clinical and prognostic significance of coagulation assays in lung cancer

Respiratory Medicine

Volumn 107, Issue 3, 2013, Pages 451-457

  Tas, Faruk ^a   Kilic, Leyla ^a   Serilmez, Murat ^a   Keskin, Serkan ^a   Sen, Fatma ^a   Duranyildiz, Derya ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Coagulation tests; Lung cancer; Survival

Indexed keywords

D DIMER;

ADULT; ARTICLE; CANCER SURVIVAL; CONTROL GROUP; FEMALE; FIBRINOGEN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; SQUAMOUS CELL CARCINOMA; SURVIVAL; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CASE-CONTROL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMANS; INTERNATIONAL NORMALIZED RATIO; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84874703332     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.11.007     Document Type: Article

References (33)

1. G.H. Lyman, and A.A. Khorana Cancer, clots and consensus: new understanding of an old problem J Clin Oncol 27 2009 4821 4826
2. H.F. Dvorak Thrombosis and cancer Hum Pathol 18 1987 275 284
3. A. Amirkhosravi, T. Meyer, M. Amaya, M. Davila, S.A. Mousa, T. Robson, and J.L. Francis The role of tissue factor pathway inhibitor in tumor growth and metastasis Semin Thromb Hemost 33 2007 643 652
4. F.R. Rickles, M.N. Levine, and H.F. Dvorak Abnormalities of hemostasis in malignancy R.W. Colman, J. Hirsh, V.J. Marder, A.W. Clowes, J.N. George, Hemostasis and thrombosis. Basic principles and clinical practice 4th ed. 2001 Lippincott Williams and Wilkins Philadelphia 1131 1152
5. C. Oberhoff, C. Rollwagen, A.M. Tauchert, O. Hoffman, U.H. Winkler, and A.E. Schindler Perioperative development of a thrombogenic risk profile in patients with carcinoma of breast: a cause of increased thrombosis Eur J Gynaecol Oncol 21 2000 560 568
6. B. Miller, and L. Heilmann Hemorheologic variables in breast cancer patients at the time of diagnosis and during treatment Cancer 62 1988 350 354
7. M. Oya, Y. Akiyama, T. Okuyama, and H. Ishikawa High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer Jpn J Clin Oncol 31 2001 388 394
8. B. Bottasso, D. Mari, R. Coppola, N. Santoro, M. Vaglini, and P.M. Mannuci Hypercoagulability and hyperfibrinogenemia in patients with melanoma Thromb Res 81 1996 345 352
9. M.Z. Wojtukiewicz, L.R. Zacharski, T.E. Moritz, K. Hur, R.L. Edwards, and F.R. Rickles Prognostic significance of blood coagulation tests in carcinoma of lung and colon Blood Coagul Fibrinolysis 3 1992 429 437
10. G. Buccheri, D. Ferrigno, C. Ginardi, and C. Zuliani Haemostatic abnormalities in lung cancer: prognostic implications Eur J Cancer 33 1997 50 55
11. R. Seitz, N. Rappe, M. Drus, A. Immel, M. Wolf, and M. Maasberg Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumor stage and prognosis Blood Coagul Fibrinolysis 4 1993 249 254
12. E.C. Gabazza, O. Taguchi, T. Yamakami, M. Machishi, H. Ibata, and S. Suzuki Evaluating prethrombotic state in lung cancer using molecular markers Chest 103 1993 196 200
13. J. Aisner, M. Goutsou, and L.H. Maurer Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study J Clin Oncol 10 1992 1230 1236
14. E. Brambilla, W.D. Travis, T.V. Colby, B. Corrin, and Y. Shimosato The new World Health Organization classification of lung tumors Eur Respir J 18 2001 1059 1068
15. F.C. Detterbeck, D.J. Boffa, and L.T. Tanoue The new lung cancer staging system Chest 136 2009 260 272
16. E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, and L. Rubinstein New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
17. A. Falanga Thrombophilia in cancer Semin Thromb Hemost 31 2005 104 110
18. F.R. Rickles, and R.L. Edwards Activation of blood coagulation in cancer: Trousseau's syndrome revisited Blood 62 1983 14 31
19. K. Blackwell, Z. Haroon, and G. Broadwater Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status J Clin Oncol 18 2000 600 608
20. O. Taguchi, E.C. Gabazza, H. Yasui, T. Kobayashi, M. Yoshida, and H. Kobayashi Prognostic significance of plasma D-dimer levels in patient with lung cancer Thorax 52 1997 563 565
21. R.L. Edwards, F.R. Rickles, and T.E. Moritz Abnormalities of blood coagulation tests in patients with cancer Am J Pathol 88 1987 596 602
22. C. Bartoloni, L. Guidi, and A. Tricerri Latent coagulation disorders evaluated by the assay of plasma thrombin-antithrombin III complexes in a large series of 'solid tumors' Oncology 49 1992 426 430
23. J.L. Yu, L. May, V. Lhotak, S. Shahrzad, S. Shirasawa, J.L. Weitz, B.L. Coomber, N. Mackman, and J.W. Rak Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis Blood 105 2005 1734 1741
24. T. Sato, I. Tsujino, D. Ikeda, M. Ieko, and M. Nishimura Trousseau's syndrome associated with tissue factor produced by pulmonary adenocarcinoma Thorax 61 2006 1009 1010
25. C.A.J. Owen, E.J.W. Bowie, and J.H.J. Thompson The diagnosis of bleeding disorders 1975 Little, Brown & Company Boston
26. D. Ferrigno, G. Buccheri, and I. Ricca Prognostic significance of blood coagulation tests in lung cancer Eur Respir J 17 2001 667 673
27. G. Buccheri, P. Torchio, and D. Ferrigno Plasma levels of D-dimer lung carcinoma. Clinical and prognostic significance Cancer 97 2003 3044 3052
28. G. Altiay, A. Ciftci, M. Demir, Z. Kocak, N. Sut, E. Tabakoglu, N. Hatipoglu, and T. Caglar High plasma D-dimer level is associated with decreased survival in patients with lung cancer Clin Oncol 19 2007 494 498
29. D. Antoniou, G. Pavlakou, G. Stathpoulos, I. Karydis, E. Chondrou, and C. Papageorgiou Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer Lung Cancer 53 2006 205 210
30. S. Madoiwa, N. Komatsu, and J. Mimuro Developmental expression of plasminogen activator inhibitor- I (PAI-I) associated with thrombopoietin- dependent megakaryocytic differentiation Blood 94 1999 475 482
31. T. Yamaguchi, Y. Yamamoto, S. Yokota, M. Nakagawa, M. Ito, and T. Ogura Involvement of interleukin-6 in the elevation of plasma fibrinogen levels in lung cancer patients Jpn J Clin Oncol 28 1998 740 744
32. K. Kawai, J. Kitayama, N.H. Tsuno, E. Sunami, and H. Nagawa Hyperfibrinogenemia after preoperative chemoradiotherapy predicts poor response and poor prognosis in rectal cancer Int J Colorectal Dis 26 2011 45 51
33. E.A. Akl, S. Rohilla, M. Barba, F. Sperati, I. Terrenato, P. Muti, F. Bdair, and H.J. Schünemann Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review Cancer 113 2008 1685 1694